Literature DB >> 28363807

Repetitive transcranial magnetic stimulation reduces anxiety symptoms, drug cravings, and elevates 1H-MRS brain metabolites: A case report.

Antoine Hone-Blanchet1, Marine Mondino1, Shirley Fecteau2.   

Abstract

Entities:  

Keywords:  ACC; DLPFC; Glx; MRS; Striatum; Substance use disorder; rTMS

Year:  2017        PMID： 28363807     DOI： 10.1016/j.brs.2017.03.007

Source DB:  PubMed          Journal:  Brain Stimul        ISSN： 1876-4754            Impact factor:   8.955


× No keyword cloud information.
  4 in total

Review 1.  Metabolomic Biomarkers in Anxiety Disorders.

Authors:  Elke Humer; Christoph Pieh; Thomas Probst
Journal:  Int J Mol Sci       Date:  2020-07-06       Impact factor: 5.923

2.  γ-aminobutyric acid and glutamate/glutamine alterations of the left prefrontal cortex in individuals with methamphetamine use disorder: a combined transcranial magnetic stimulation-magnetic resonance spectroscopy study.

Authors:  Hang Su; Tianzhen Chen; Na Zhong; Haifeng Jiang; Jiang Du; Ke Xiao; Ding Xu; Zheng Wang; Min Zhao
Journal:  Ann Transl Med       Date:  2020-03

3.  Effects of Repetitive Transcranial Magnetic Stimulation on Cerebellar Metabolism in Patients With Spinocerebellar Ataxia Type 3.

Authors:  Xin-Yuan Chen; Yan-Hua Lian; Xia-Hua Liu; Arif Sikandar; Meng-Cheng Li; Hao-Ling Xu; Jian-Ping Hu; Qun-Lin Chen; Shi-Rui Gan
Journal:  Front Aging Neurosci       Date:  2022-04-25       Impact factor: 5.702

4.  Influence of Repetitive Transcranial Magnetic Stimulation on Human Neurochemistry and Functional Connectivity: A Pilot MRI/MRS Study at 7 T.

Authors:  Heidi Gröhn; Bernadette T Gillick; Ivan Tkáč; Petr Bednařík; Daniele Mascali; Dinesh K Deelchand; Shalom Michaeli; Gregg D Meekins; Michael J Leffler-McCabe; Colum D MacKinnon; Lynn E Eberly; Silvia Mangia
Journal:  Front Neurosci       Date:  2019-11-27       Impact factor: 4.677
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.